H

Heron Therapeutics

D
HRTX
USD
-0.03
(-1.6713%)
Market Closed
50,345.00
Volume
-1.98
EPS
-
Div Yield
-7.060000
P/E
267,694,050.01
Market Cap
Today
-1.6713%
1 Week
0.857%
1 Month
-9.949%
6 Months
-38.287%
12 Months
124.099%
Year To Date
3.519%
All Time
0%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news
More
Related Instruments
S
SGEN
(%)
USD
B
BLUE
-0.0729
(-16.2614%)
USD
C
CRBP
-0.36
(-1.9027%)
USD
S
SRPT
-7.62
(-5.9531%)
USD
ALNY
ALNY
-0.795
(-0.2913%)
USD
I
INCY
2.2
(2.7445%)
USD
GILD
GILD
6.23
(6.7946%)
USD
B
BMRN
0.785
(1.1869%)
USD
A
ACAD
1.42
(8.993%)
USD
E
EXEL
0.66
(1.8782%)
USD

Title:
Heron Therapeutics

Sector:
Healthcare
Industry:
Biotechnology
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.
Do you need help or have a question?
Contact Us